Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df7d82eba5bc85208002709fffcb933e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cbaf27b0e5029d0ba0315ee19bb6bd61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e431f939326f23f5817e92f586a86888 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9ec299e15d91ea5b17eba08b5772c8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25e41fb6683b0dd4b5f27a090addb373 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56560534bef2b97b29fe78b1d71326db |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 |
filingDate |
2012-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e7f3c7091c90d1127541f5cd9cdaec7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00d9aa014071883c63294212c44338d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63e59ca01000f39b0033ee66e721f9eb |
publicationDate |
2016-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9327013-B2 |
titleOfInvention |
Activity enhancer for anticancer agent |
abstract |
An activity enhancer for an anticancer agent includes, as an active ingredient, a D-form amino acid residue-containing FNIII14 polypeptide, the D-form amino acid residue-containing FNIII14 being a polypeptide FNIII14 represented by SEQ ID NO: 1 in which at least one of amino acid residues at positions 1 to 13 is a D-form amino acid residue. An anticancer composition includes the activity enhancer for an anticancer agent and an anticancer agent. |
priorityDate |
2011-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |